Premium
Enveric Biosciences Inc (ENVB)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline include... Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN). Show more
New patents provide additional composition of matter and methods of use claims for Enveric’s EVM301 series neuroplastogenic molecules, and recently out-licensed tryptamine-derived prodrugs...
Dose-proportional oral bioavailability without clinical signs, including those associated with hallucinogenic compounds, was demonstrated in rat and dog pharmacokinetic (PK) studies while...
Advanced pre-IND activities and research for lead candidate, EB-003, a novel neuroplastogenic molecule designed to treat severe mental health disorders Announced the expansion of patent...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0256 | -7.21126760563 | 0.355 | 0.3749 | 0.314 | 99957 | 0.3391622 | CS |
| 4 | -0.01135 | -3.33088774762 | 0.34075 | 0.3749 | 0.3036 | 154791 | 0.33335922 | CS |
| 12 | -0.1446 | -30.5063291139 | 0.474 | 0.555 | 0.3036 | 562367 | 0.42829413 | CS |
| 26 | -0.3306 | -50.0909090909 | 0.66 | 0.77 | 0.3036 | 822931 | 0.52004843 | CS |
| 52 | -1.0506 | -76.1304347826 | 1.38 | 2.92 | 0.3036 | 1622446 | 1.1192531 | CS |
| 156 | -0.8206 | -71.3565217391 | 1.15 | 14.87 | 0.1551 | 1371420 | 1.66825766 | CS |
| 260 | -5.4706 | -94.3206896552 | 5.8 | 14.87 | 0.1551 | 1858175 | 2.46565123 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
